Pages that link to "Q37438267"

The following pages link to Critical issues for successful immunotherapy in Alzheimer's disease: development of biomarkers and methods for early detection and intervention (Q37438267):

Displaying 23 items.

• The clinical problem of symptomatic Alzheimer disease and mild cognitive impairment (Q26849795) (← links)
• Multivariate protein signatures of pre-clinical Alzheimer's disease in the Alzheimer's disease neuroimaging initiative (ADNI) plasma proteome dataset (Q28730795) (← links)
• The MultiTEP platform-based Alzheimer's disease epitope vaccine activates a broad repertoire of T helper cells in nonhuman primates (Q33560798) (← links)
• RTN/Nogo in forming Alzheimer's neuritic plaques (Q33926137) (← links)
• Immunotherapy for Alzheimer’s disease (Q34783722) (← links)
• Targets for AD treatment: conflicting messages from γ-secretase inhibitors (Q34792043) (← links)
• Visinin-like protein-1: diagnostic and prognostic biomarker in Alzheimer disease (Q35158065) (← links)
• CSF VILIP-1 predicts rates of cognitive decline in early Alzheimer disease. (Q35835717) (← links)
• Cerebrospinal Fluid Markers of Neurodegeneration and Rates of Brain Atrophy in Early Alzheimer Disease (Q36001286) (← links)
• A fresh perspective from immunologists and vaccine researchers: active vaccination strategies to prevent and reverse Alzheimer's disease (Q36240389) (← links)
• Preventive immunization of aged and juvenile non-human primates to β-amyloid (Q36391157) (← links)
• Diagnostic and Prognostic Utility of the Synaptic Marker Neurogranin in Alzheimer Disease (Q36885492) (← links)
• Vaccination as a therapeutic approach to Alzheimer's disease. (Q37681432) (← links)
• Immunotherapy for neurodegenerative diseases: focus on α-synucleinopathies (Q38079317) (← links)
• Adaptive lymphocyte profiles correlate to brain Aβ burden in patients with mild cognitive impairment. (Q38657074) (← links)
• Risk Stratification Using Cerebrospinal Fluid Biomarkers in Patients with Mild Cognitive Impairment: An Exploratory Analysis. (Q38960660) (← links)
• Preventing formation of reticulon 3 immunoreactive dystrophic neurites improves cognitive function in mice (Q42794012) (← links)
• Comparison of Efficacy of Preventive and Therapeutic Vaccines Targeting the N Terminus of β-Amyloid in an Animal Model of Alzheimer's Disease (Q45300233) (← links)
• A Novel Therapeutic Approach to Treat Alzheimer's Disease by Neurotrophic Support During the Period of Synaptic Compensation. (Q52644594) (← links)
• Using Cerebrospinal Fluid Biomarker Testing to Target Treatment to Patients with Mild Cognitive Impairment: A Cost-Effectiveness Analysis. (Q53416948) (← links)
• The Physiological Roles of Amyloid-β Peptide Hint at New Ways to Treat Alzheimer's Disease. (Q55411317) (← links)
• Consequences of redefining Alzheimer's disease in terms of amyloid burden without regard to cognitive decline (Q57455017) (← links)
• Testing a MultiTEP-based combination vaccine to reduce Aβ and tau pathology in Tau22/5xFAD bigenic mice (Q92055304) (← links)